Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion type Assertion NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_head.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion description "[Here, using novel phosphospecific antibodies, we demonstrate that phosphorylation of CRMP2 at Ser522 (Cdk5-mediated) is increased in Alzheimer's disease (AD) brain, while CRMP2 expression and phosphorylation of the closely related isoform CRMP4 are not altered.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_provenance.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion evidence source_evidence_literature NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_provenance.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion SIO_000772 17683481 NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_provenance.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion wasDerivedFrom befree-20140225 NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_provenance.
- NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_assertion wasGeneratedBy ECO_0000203 NP615328.RA9GhFUlAlASZ76o2ve6v5QkjuuqwxOepGbpCMAIFbWP4130_provenance.